I read with interest the article “Mechanical complications of everolimus-eluting stents associated with adverse events: an intravascular ultrasound study” by Inaba and colleagues1 which provides interesting information on stent fracture with a contemporary drug-eluting stent, and is complementary to the study recently published by Kuramitsu and colleagues2.
However, similarly to the Kuramitsu study, the term “everolimus-eluting stent” as used in this manuscript is misleading. Mechanical stent complications including stent recoil, stent fracture and longitudinal stent deformation (LSD) are not primarily related to the polymer or drug coating but to the underlying stent design. It appears that ...
Sign in to read and download the full articleForgot your password?
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com